Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 189
Severity: 8192
Message: substr(): Passing null to parameter #1 ($string) of type string is deprecated
Filename: frontend/article.php
Line Number: 189
Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 190
Severity: 8192
Message: substr(): Passing null to parameter #1 ($string) of type string is deprecated
Filename: frontend/article.php
Line Number: 190
Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 213
Severity: 8192
Message: substr(): Passing null to parameter #1 ($string) of type string is deprecated
Filename: frontend/article.php
Line Number: 213
Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 214
Severity: 8192
Message: substr(): Passing null to parameter #1 ($string) of type string is deprecated
Filename: frontend/article.php
Line Number: 214
We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 424
1College of Pharmacy, Paniv, Malshiras
2K. V. N. Naik SP Sanstha's Institute of pharmaceutical Education and Research, Canada Corner, Nashik, 422002, Maharashtra, India
Co-crystals are solid-state complexes formed by an active pharmaceutical ingredient (API) and a co-former in a defined stoichiometric ratio. They offer a promising strategy to address the challenges of poor solubility and stability in pharmaceutical formulations. This review delves into the mechanisms by which co-crystals improve drug solubility, enhance stability, and optimize bioavailability. We explore the different techniques used in co-crystal formation, their characterization, advantages over traditional formulations, and challenges in commercialization and regulatory approval. Additionally, we review case studies highlighting successful co-crystal applications and discuss future directions for research in the field. The insights provided in this paper offer a deeper understanding of co-crystal technology and its potential to revolutionize the pharmaceutical industry.
1.1 The Need for Solubility Enhancement in Drug Development
One important aspect impacting a drug's absorption and bioavailability is its solubility in aqueous solutions. Poor solubility affects about 40% of novel drug candidates, which restricts their potential for therapy and makes formulation more difficult [1]. For BCS Class II medications, which have high permeability but very little solubility, and BCS Class IV substances, which have both small pores and low solubility, poor solubility is a major obstacle for the pharmaceutical business [2]. The goal of pharmaceutical formulation strategies has long been to increase drug solubility using techniques including lipid-based systems, solid dispersion, and salt creation. But these methods frequently have drawbacks in terms of reliability, scalability, and regulatory approval. An inventive solution to these problems that preserves the drug's chemical stability is co-crystal formation.
1.2 Introduction to Co-Crystals
A substance called an API and a co-former molecule combine to form crystalline complexes known as co-crystals. In contrast to salts, which are made up of ionic contacts, co-crystals are usually made up of neutral molecules bound together by non-covalent connections like van der Waals forces, π-π stacking, and hydrogen bonds. [3]. Because co-crystals provide a way to change a medication's chemical and physical characteristics without affecting its pharmacological activity, they have drawn more attention in the drug development process. Co-crystals created by joining a medication molecule with a co-former may show:
• Increased solubility and rate of dissolution [4].
• Enhanced stability in a range of environmental circumstances [5].
• Release profiles were modified [6].
Co-crystal formation enables a more precise method of medication formulation, maximizing both patient compliance and therapeutic efficacy.
2. Co-Crystal Formation and Mechanism
Vaishnavi Adsul*, Dr. Swapnil phade, Pratik Bhabad, Co-Crystals in Enhancing Drug Solubility and Stability: A Comprehensive Review, Int. J. Sci. R. Tech., 2025, 2 (5), 268-273. https://doi.org/10.5281/zenodo.15400763
10.5281/zenodo.15400763